Clinical Trials Browser

Phase 1/2 × abexinostat × 1 year × Clear all

NCT04024696 2025-04-10

A Clinical Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Abexinostat in Chinese Patients

Phase 1/2 Active not recruiting

Lymphoma, Non-Hodgkin